Item | Non intervention | Intervention | P |
---|---|---|---|
n (%) | n (%) | ||
Age (year) | |||
Mean ± Standard deviation | 53.3 ± 11.1 | 56.3 ± 9.0 | 0.313 |
Gender | |||
Female | 19 (100) | 20 (100) | 1.000 |
Male | 0 (0) | 0 (0) | |
PS | |||
0 | 19 (100) | 20 (100) | 1.000 |
1 | 0 (0) | 0 (0) | |
2 | 0 (0) | 0 (0) | |
Stage | |||
I | 3 (16.7) | 8 (38.1) | 0.238 |
II | 8 (44.4) | 11 (52.4) | |
III | 5 (22.2) | 2 (9.5) | |
IV | 3 (16.7) | 0 (0) | |
HER2 | |||
0 | 1 (5.6) | 1 (4.8) | 0.213 |
+ 1 | 9 (44.4) | 13 (61.9) | |
+ 2 | 6 (33.3) | 2 (9.5) | |
FISH- | 4 | 2 | |
FISH+ | 2 | ||
+ 3 | 3 (16.7) | 5 (23.8) | |
ER | |||
+ | 15 (77.8) | 15 (71.4) | 0.223 |
± | 2 (11.1) | 4 (19.0) | |
– | 2 (11.1) | 2 (9.5) | |
PgR | |||
+ | 10 (55.6) | 11 (52.4) | 0.223 |
± | 4 (16.7) | 5 (23.8) | |
– | 5 (27.8) | 5 (23.8) | |
Purpose of chemotherapy | |||
Neoadjuvant | 11 (61.1) | 8 (40.0) | 0.343 |
Adjuvant | 8 (38.9) | 12 (60.0) | |
Regimen | |||
Anthracyclines | 0.110 | ||
EC (every 3w) | 11 (61.1) | 11 (55.0) | |
FEC (every 3w) | 0 (0) | 3 (15.0) | |
Taxanes | |||
TC (every 3w) | 3 (16.7) | 6 (30.0) | |
nabPTX (every 3w) | 1 (5.6) | 0 (0) | |
PTX + BV (every 4w) | 1 (5.6) | 0 (0) | |
Others | |||
CMF (every 3w) | 3 (16.7) | 0 (0) | |
Marital status | |||
Married | 13 (68.4) | 16 (80.0) | 0.480 |
Unmarried | 6 (31.6) | 4 (20.0) | |
Cohabitants | |||
Yes | 19 (100) | 19 (95.0) | 1.000 |
No | 0 (0) | 1 (5.0) | |
Current occupation | |||
Employer | 12 (63.2) | 9 (45.0) | 0.341 |
Non-employee | 7 (36.8) | 11 (55.0) |